1 / 54

The NF-  B/Rel family

The NF-  B/Rel family. The NF-κB/Rel family. A family of signal-responsive transcription factors rapid response som ikke requires proteinsyntese Involved in proinflammatory response: a first line of defense against infectious diseases and cellular stress

reynaldor
Download Presentation

The NF-  B/Rel family

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. The NF-B/Rel family

  2. The NF-κB/Rel family • A family of signal-responsive transcription factors • rapid response som ikke requires proteinsyntese • Involved in proinflammatory response: a first line of defense against infectious diseases and cellular stress • Signal Activated NF-B  immune defence activated • Immune response, inflammatory response, accute phase response • NFkB also a major anti-apoptopic factor • aberrant activation of NF-B = one of the primary causes of a wide range of human diseases like in Inflammatory diseases, Rheumatoid arthritis, Asthma, Atherosclerosis, Alzheimer • Persistent activated in many cancers - help keeping cancer cells alive • NFkB also promoting growth • Activated NF-B  cyclin D expression enhanced  growth • Drug against NFkB = putative anti-cancer drug

  3. The NF-B/Rel family • Characteristic feature: homo- and heterodimeric TFs, which in non-stimulated cells are found inactive in the cytoplasm [in a complex with IB-repressors]. • Active DNA-binding form: Dimers with different members of the NF-B/Rel family • Inactive cytoplasmic form: inhibitory factor/domain in addition • Upon stimulation, active NF-B rapidly translocates to the nucleus where it binds B-sites and activates target genes. • Rapid response - minutes • Signal Activated NF-B  immune defence activated

  4. Signals Cytoplasm inactive Nucleus active Signal transduction pathway

  5. NF-κB/Rel proteins

  6. Common DBD: Rel-homology domain (RHD) • RHD: 300aa conserved domain with several functions • DNA-binding (N-terminal half) • dimerization (C-terminal half) • IB-interaction (C-terminal half) • NLS (C-terminal half) • kalles også NRD (=NF-kB, Rel, Dorsal) dimerization IkB-interaction NLS Spec.DNA-binding

  7. Homo- and heterodimers • NF-B/Rel proteins = Homo- and hetero-dimeric TFs that in resting cells are retained in the cytoplasm in complex with IB. • Mature B-cells: constitutively nuclear activator • Bound to kappa immunoglobuline light-chain enhancer  its name

  8. Two main classes of RHDs • Rel with TAD (dimeric with ≥ 1 Rel-monomers which are potent transactivators) synthesized in their mature form • Rel or c-Rel (as well as v-Rel) • RelA (p65) • RelB • Drosophilas dorsal and Dif • p50/52 without TAD (homodimers with no transactivation properties) synthesized as precursors that are processed • Precursor forms have internal IB inhibitor function • RHD linked to inhibitory domain through Gly-rich linker (protease sensitive) • Blocks DNA-binding and translocation to nucleus • p105 undergoes proteolytic maturation to p50 [NF-B1] • Proteolytic degradation to p50 is signal dependent, requires ATP and occurs through a ubiquitin-dependent proteasome pathway • Also transcription from an intronic promoter expressionof IkB- • p100 undergoes proteolytic maturation to p52 [NF-B2] • p50/52 are distinct gene products with very similar properties

  9. Rel homology domain p105 C-terminal IkB-like domains p50 p100 p52 RelA(p65) cRel Acitvation domains RelB Two main classes of RHDs - TAD +TAD

  10. RHD proteins Ankyrin repeats RHD

  11. Dimer-formation • Dimer-formation necessary for DNA-binding • each subunit interacts with one half site • B-sites symmetric: 5´-GGGRNNYYCC-3´ • Most combinations allowed • Different heterodimers vary with respect to • preference for different kB-seter • Kinetics of nuclear translocation • p50/p65 rapid, p50/Rel slow • abundance in different cells • Exception: RelB which forms dimer only with p50/p52 • Common form: p50/p65 (NF-kB1/RelA) • most abundant, found in most cells • --5´-GGGRNNYYCC-3´-- • - 3´-CCCYNNRRGG-5´--

  12. 3D structure - DNA interaction • Crystal structures: • p50-p50-DNA and p50-p65-DNA • Two distinct domains • 1. N-terminal - specific DNA contact • Compact core in the form of an antiparalell -barrel from which loops protrude • The loop between AB = recognition loop with base contacts in major groove • Critical for specificity = R57-R59-E63 • C62 responsible for redox-sensitivity • 2. C-terminal domain responsible for dimerisation + nonspecific DNA-phosphate contact • Conserved interphase explains why most heterodimers are possible C-terminal domain N-terminal domain

  13. Structure: NFkB (p50-p65) + DNA Side view • -barrel core with protrding loops • The AB loop = recognition loop • Specificity R57-R59-E63 • C62 redox-sensitivity

  14. 3D structure - DNA interaction • Characteristic features of DNA-interaction • Each monomer contacts a separate half site • “Closing jaws” mechanism for DNA-binding • The protein encloses DNA • Unusual strong binding (Kd = 10-12 M) • Dissociation requires opening of the jaws through a flexible linker

  15. 3D structure - protein interaction • Interaction with HMGI(Y) • IFN- promoter: HMGI(Y) binds AT-rich centre of B-sites in minor groove • The structure contains a corresponding open space • Interaction with IB • IB binding in an opening over the dimer-interphase • IB binding blocks DNA-binding IkB HMG I(Y) • --5´-GGGRNNYYCC-3´-- • - 3´-CCCYNNRRGG-5´--

  16. The I-B family

  17. The I-B proteins Ankyrin repeats N-terminal Regulatory domain

  18. The IkB-family • Inhibitory function • impedes DNA-binding • blocks NLS and abolish translocation to nucleus • Several members (at least 7 mammalian) • IB- and IB- • IB-and IB- • Bcl-3 • p105 and p110 • IkBR • Common features: • ankyrin-repeats which are necessary for RHD-interaction • 30-33 aa motif repeated 3 - 7x • C-terminal acidic-region necessary for inhibition of DNA-binding • C-terminal PEST-sequence involved in protein-degradation • Specificity • Ex. IkB- inhibits DNA-binding of p65/p50 but not of p50/p50

  19. NFkB-IkB complex IkB HMG I(Y)

  20. Signaling • IκB - a key element in the canonical NFkB signaling pathway

  21. Cytoplasmic retention due to interaction with IB-family proteins Signal • Two types of inactive complexes in cytoplasm • Trimers = RHD-Homo-or heterodimers bound to an IB • Heterodimers = Rel-protein + unprocessed RHD-precursor (p105, p110) • Signal→[dissociation]→ degradation • Induction signal  phosphorylation of both IB and p105  IB degradation or p105 processering  active dimers that are translocated to the nucleus. • One type of signal  two N-terminal serines (S32 and S36) become phosphorylated • Another type of signal  two C-terminal serines become phosphorylated in p105 • phosphorylation probably more a signal for degradation than for dissociation • Ubiquitin-pathway involved • Stimulation  rapid degradation of IB • complete after 10 min • No traces of IB • phosphorylation of IB • → multiubiquitylation in K21, K22 • → degradation through a ubiquitin-proteasome pathway • + proteasome-inhibitors → phospho-IkB remains associated with NFkB Signal

  22. Several IB-factors with different properties • IB-: Rapid transient response • IB- best characterized • all stimuli  degradation of IB- • ex: TNF-rapid and transient activation of NF-kB • IB-: Sustained response • Only certain stimuli  degradation of IB- • ex: LPS or IL-1degradation of both IB-and IB- activation of NF-kB lasting for hours • Bcl-3: repressor and activator • inhibits certain complexes like a normal IB • But may also associate with DNA-bound p50 and p52 dimers (lacking TAD) and provide transactivation properties

  23. Signaling pathways

  24. . . . . Signal transduction pathways + + NF-kB + Upstream and downstream Upstream Downstream

  25. . . . . Signal transduction pathways + + NF-kB + Multiple signalling pathways activate NF-B • Several signalling pathways converge by activation of NF-B • NF-B respond to a broad range of different stimuli • Virus infection (HIV, hepatite B), virus proteins (tax, E1A) and dsRNA • Cytokines (TNF, IL-1 and IL-2) • Bacterial LPS • stimulation of antigen reseptor on B- and T-cells • calcium ionophores • protein synthesis inhibitors • UV and X-ray • sphingomylenase/ceramide • phorbol esters • nitrogen oxide

  26. Signals Cytoplasm inactive Nucleus active Three signal transduction pathways

  27. Signaling hits I-B through phosphorylation • Two N-terminal serines becomes phosphorylated • TNF-signalling pathways: TNF-receptor  TRADD/TRAF  IKK IB  • IB-kinase complex central in the signaling pathway • A large 500-900 kDa IKK (IB-kinase) complex that is induced by cytokines • Two key subunits: IKK and IKK

  28. The IB-kinase complex central in the pathway IB-kinase complex

  29. The IKKb-kinase becomes activated through phosphorylation Signal Upstream kinase • Activation loop in IKKb • Two serines bocomes phosphorylated in a signal dep manner (IL1, TNF) • Ala-mutants block the signalling pathway, Glu-mutants lead to a constitutive active kinase • Signal  phosphorylation • phosphorylation of loop necessary for NFkB-activation of cytokines • Attenuation • phosphorylated activation loop  altered HLH-kinase domain interaction  reduced kinase-aktivitet IKKß Ser-OH Ser-P Ser-OH Ser-P P P P P inactive active inactive Autophosphorylation IkB

  30. The first pathway - the classical pathway • Receptor triggered by pro-inflammatory cytokines • such as tumour necrosis factor (TNF)-α • Recruitment of various adaptors • including TRADD (TNF-receptor associated death domain protein), RIP (receptor interacting protein and TRAF2 (TNF-receptor-associated factor 2) to the cytoplasmic membrane. • Recruitment and activation of the classical IκB-kinase (IKK) complex • which includes the scaffold protein NEMO (NF-kB essential modulator; also named IKKγ), IKKα and IKKβ kinases. • The IKK complex phosphorylates IκBα on Ser32 and Ser36 • Leading to ubiquitylation and degradation via the proteasome pathway • The free p50-p65 migrates to the nucleus where it activates target genes involved in immune response

  31. The first pathway - the classical pathway dep on IKKβ Triggered by microbial and viral infections and exposure to proinflammatory cytokines

  32. Signal upstream kinase IKKß Ser-OH Ser-P Ser-OH Ser-P inactive active IkB Why two kinases? • In vitro: IKKa ≈ IKKb • 52% identity • Similar kinase activity • In vivo: IKKa ≠ IKKb • Ala-mutants of IKKß NFkB response dead • Glu-mutants of IKKß NFkB response independent of signals • Ala-mutants of IKKa  NFkB response unaffected • Glu-mutants of IKKa  NFkB response unaffected • Is IKKa totally unlinked to NFkB?

  33. The next indication: KO phenotypes of IKKa ≠ IKKb • Knock-out of of IKKloss of B- and T-cell response • Normal development • Mice dead at day 13.5, liver destroyed due to massive apoptosis • Lack of IKK lack of active NFkB  lack of protection against apoptosis  massive cell death • Lost T-cell response because Apoptosis important for T-cell development • Knock-out of of IKK  • , epidermis 5-10x thicker than normal, highly undifferentiated • sl • Normal number of B- and T-cells, but B-cells not fully differentiated

  34. A separate signaling pathway through IKKa • A desparate postdoc looked at all the 50 components - all behaved normal, except one • The proteolytic maturation of the p100 precursor to p52 [NF-B2] was defective in the IKK •  processing depends on NIK • Hypothesis: NIK acts through IKK

  35. The solution Processing depends on IKKa Target of IKKb

  36. A separate signalling pathwayinvolving only IKKα Affects NF-κB2 (p100), which preferentially dimerizes with RelB. Triggered by by cytokines such as lymphotoxin b, B-cell activating factor (BAFF) or the CD40 ligand and by viruses such as human T-cell leukaemia virus. NEMO-independent, IKKα- dependent + another kinase NIK. Induce the phosphorylation-dependent proteolytic removal of the IkB-like C-terminal domain of NF-κB2 B-cell maturation A role in adaptive immunity A role in innate immunity

  37. Two kinases- two main signaling pathways • The canonical NF-kB activation pathway (left) • Applies to RelA-p50 and c-Rel-p50 • Retained in cytoplasm by IkB • Triggered by microbial and viral infections and exposure to proinflammatory cytokines • Depends mainly on the IKKb subunit of the IKK complex. • The second pathway (right) • Affects NF-kB2, which preferentially dimerizes with RELB. • Triggered by members of the tumour-necrosis factor (TNF) cytokine family • Depends selectively on activation of the IKKa subunit + another kinase NIK. • Induce the phosphorylation-dependent proteolytic removal of the IkB-like C-terminal domain of NF-kB2.

  38. A third signalling pathway independent on both IKKs • classified as atypical because it is independent of IKK • proteasome still required • triggered by DNA damage such as UV or doxorubicin • UV radiation induces IkBa degradation via the proteasome, but the targeted serine residues are located within a C-terminal cluster, which is recognized by the p38-activated casein kinase 2 (CK2)

  39. Connectivity map of the TNF-α/NF-κB signal transduction pathway

  40. Seminar

  41. Target genes

  42. . . . . Signal transduction pathways + + NF-kB + Upstream and downstream Upstream Downstream

  43. Families of target genes • Immune response • Cytokines, • Chemokines • Cytokine and immuno-receptors • Adhesion molecules • Acute-phase proteins • Stress-responsive genes NF-kB is both being activated by and inducing the expression of inflammatory cytokines NF-kB activation can spread from cell to cell

  44. Negative feedback:Attenuation of respons • Negative loop: IB- under direct control of NF-B • Activated NF-B translocated to the nucleus will activate expression of IB- • Newly synthesized IB-will bind up and inactivate remaining NF-B in the cytoplasma • Excess IB-will migrate to the nucleus and inactivate DNA-bound NF-B (contains both NLS and nuclear eksport signal) • A20 protein another strongly induced negative feedback protein • Immunosupressive effect of glucocorticoids • Probably a direct effect of glucocorticoids enhancing the expression of IB-which then binds up and inactivates NF-B in the cytoplasm, leading to reduced immune- and inflammatory response

  45. Target genes:Link to cancer • Tumorigenesis requires 6 types of alterations • Hanahan & Weinberg 2000 • Several of these can be caused by perturbation in NF-B or linked signaling molecules • Tumour cells in which NF-B is constitutively active are highly resistant to anticancer drugs or ionizing radiation. Angiogenesis Metastasis

  46. Disease links

  47. Viruses exploit NF-kB • several patogenic viruses exploit the NF-kB system for their own profit • Incorporation of kB-sites in virus DNA cause enhanced expression of virus-genes when the immune response is activated • Virus proteins activate NF-kB

  48. Disease links

  49. Constitutivelynuclear NF-kB • Disruption of the regulatory mechanism  aberrant activation of NFkB = one of the primary causes of a wide range of human diseases • Inflammatory diseases • Rheumatoid arthritis • Asthma • Atherosclerosis • Alzheimer

  50. Link: inflammation - cancer • A causal connection between inflammation and cancer has been suspected for many years. • NF-Bmight serve as the missing link between these two processes. • NF-Bbecomes activated in response to inflammatory stimuli • Constitutive activation of NF-Bhas been associated with cancer,

More Related